This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioPharm America
BioPharm America is merging with LSX USA
Hynes Convention Center | Boston, MA

September 11–12, 2024

Chiima Therapeutics


Company Description or Summary:

Chiima Therapeutics is a pre-clinical early-stage biotech company committed to changing the chronic and acute pain treatment landscape. The current focus is on developing early-stage molecules that deliver safe, effective, and easy-to-use therapeutic compounds for acute and chronic pain. We are currently investigating our lead compound CHM-001 for treatment in local analgesic treatment in endometriosis-related pain in adult women. Endometriosis-related pain is a serious concern.